Entera Bio (ENTX) Net Margin (2021 - 2025)

Entera Bio has disclosed Net Margin across 4 years of filings, most recently posting 6102.38% for Q1 2025.

• Quarterly Net Margin changed N/A year-over-year to 6102.38% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 27600.0% (down 2227348.0% YoY) and the FY2025 annual result came in at 27235.71%, down 2196444.0% from the prior year.
• Net Margin slipped to 6102.38% in Q1 2025, from 2875.61% in the prior quarter.
• Over five years, Net Margin peaked at 1462.42% in Q1 2021 and troughed at 38337.5% in Q3 2022.
• A 4-year average of 8454.76% and a median of 4712.18% in 2022 frame the typical range for Net Margin.
• Biggest YoY gain for Net Margin was 410229 bps in 2022; the steepest drop was 3604179 bps in 2022.
• Tracing ENTX's Net Margin over 4 years: stood at 2484.85% in 2021, then plunged by 772 bps to 21678.57% in 2022, then jumped by 87 bps to 2875.61% in 2024, then tumbled by 112 bps to 6102.38% in 2025.
• Business Quant data shows ENTX's Net Margin at 6102.38% in Q1 2025, 2875.61% in Q4 2024, and 7192.86% in Q3 2024.